Mindfulness App for Smoking Cessation in Cancer Survivors

Recruiting in Palo Alto (17 mi)

Overseen byChristine Vinci, PhD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Phase 1

Waitlist Available

Sponsor: H. Lee Moffitt Cancer Center and Research Institute

No Placebo Group

Trial Summary

What is the purpose of this trial?The purpose of the study is to obtain feedback on a new quit-smoking treatment among individuals with a cancer diagnosis using a prototype app we developed.

Eligibility Criteria

This trial is for cancer survivors who smoke and are willing to try quitting. Participants must be able to use an app on their smartphone daily, speak English, and have smoked recently. They can't join if they're using other quit-smoking treatments, are pregnant or breastfeeding, or have current psychosis.

Inclusion Criteria

I am willing to download and use the app every day.

Being able to read, write, and speak English

I am willing to attempt quitting as part of the study.

+4 more

Exclusion Criteria

Evidence of current psychosis

I am currently using medication to help me stop smoking.

Being enrolled in a smoking cessation program

+1 more

Participant Groups

The study tests a new quit-smoking treatment delivered through a prototype app designed for individuals with a cancer diagnosis. It aims to gather user feedback on the effectiveness of this mindfulness-based intervention.

1Treatment groups

Experimental Treatment

Group I: Usability TestingExperimental Treatment1 Intervention

Participants will receive brief counseling, nicotine replacement therapy, and intervention content delivered via the app.